StockData
MiniMed Group, Inc. logo

MiniMed Group, Inc. (MMED) stock

MMEDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 8, 2026Score 13/3050% below fair value
$17.78−0.87 (-4.66%)

Close on Nov 17, 2026Market cap $5.00BP/E –Yield –

MiniMed r&d expenses

Research and development expenses are spending on new products and technology.

MiniMed's R&D Expenses for the twelve months ending Apr 24, 2026 was $448.00M, up 2.8% year over year. For fiscal 2026 it was $448.00M, up 2.8% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Apr 24, 2026$448.00M+2.8%
FY2025Apr 25, 2025$436.00M-0.2%
FY2024Apr 26, 2024$437.00M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026$115.00M+7.5%
Q4 FY2026CQ1 2026Apr 24, 2026$99.00M-11.6%
Q3 FY2026CQ4 2025Jan 23, 2026$114.00M–
Q1 FY2026CQ2 2025Jul 25, 2025$125.00M–
Q4 FY2025CQ1 2025Apr 25, 2025$107.00M–
Q3 FY2025CQ4 2024Jan 24, 2025$112.00M–

More MiniMed figures

See a number that looks wrong?